OpenURL Connection Search

Select item for more details and to access through your institution.

Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy.
Published in:
2012
By:
- Toth, Peter P;
- Thakker, Kamlesh M;
- Jiang, Ping;
- Padley, Robert J
Publication type:
journal article
Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy.
Published in:
Vascular Health & Risk Management, 2012, v. 8, p. 39, doi. 10.2147/VHRM.S22601
By:
- Toth, Peter P.;
- Thakker, Kamlesh M.;
- Ping Jiang;
- Padley, Robert J.
Publication type:
Article
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.
Published in:
2010
By:
- Insull Jr, William;
- Toth, Peter P;
- Superko, H Robert;
- Thakkar, Roopal B;
- Krause, Scott;
- Jiang, Ping;
- Parreno, Rhea A;
- Padley, Robert J;
- Insull, William Jr
Publication type:
journal article
Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy.
Published in:
Vascular Health & Risk Management, 2010, v. 6, p. 1065
By:
- Insull Jr, William;
- Toth, Peter P.;
- Superko, H. Robert;
- Thakkar, Roopal B.;
- Krause, Scott;
- Ping Jiang;
- Parreno, Rhea A.;
- Padley, Robert J.
Publication type:
Article
Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
Published in:
European Journal of Health Economics, 2010, v. 11, n. 2, p. 185, doi. 10.1007/s10198-009-0165-2
By:
- de Lissovoy, Greg;
- Fraeman, Kathy;
- Teerlink, John R.;
- Mullahy, John;
- Salon, Jeff;
- Sterz, Raimund;
- Durtschi, Amy;
- Padley, Robert J.
Publication type:
Article
Determination of atrasentan by high performance liquid chromatography with fluorescence detection in human plasma.
Published in:
Biomedical Chromatography, 2001, v. 15, n. 8, p. 525, doi. 10.1002/bmc.106
By:
- Bryan, Peter D.;
- Sapochak, Lisa B.;
- Tames, Michelle M.;
- Padley, Robert J.;
- El-Shourbagy, Tawakol A.
Publication type:
Article
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Published in:
2007
By:
- Mebazaa A;
- Nieminen MS;
- Packer M;
- Cohen-Solal A;
- Kleber FX;
- Pocock SJ;
- Thakkar R;
- Padley RJ;
- Põder P;
- Kivikko M;
- SURVIVE Investigators;
- Mebazaa, Alexandre;
- Nieminen, Markku S;
- Packer, Milton;
- Cohen-Solal, Alain;
- Kleber, Franz X;
- Pocock, Stuart J;
- Thakkar, Roopal;
- Padley, Robert J;
- Põder, Pentti
Publication type:
journal article
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure.
Published in:
JAMA: Journal of the American Medical Association, 2007, v. 297, n. 17, p. 1883, doi. 10.1001/jama.297.17.1883
By:
- Mebazaa, Alexandre;
- Nieminen, Markku S.;
- Packer, Milton;
- Cohen-Solal, Alain;
- Kleber, Franz X.;
- Pocock, Stuart J.;
- Thakkar, Roopal;
- Padley, Robert J.;
- Põder, Pentti;
- Kivikko, Matti
Publication type:
Article
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
Published in:
2009
By:
- Mebazaa A;
- Nieminen MS;
- Filippatos GS;
- Cleland JG;
- Salon JE;
- Thakkar R;
- Padley RJ;
- Huang B;
- Cohen-Solal A;
- Mebazaa, Alexandre;
- Nieminen, Markku S;
- Filippatos, Gerasimos S;
- Cleland, John G;
- Salon, Jeffrey E;
- Thakkar, Roopal;
- Padley, Robert J;
- Huang, Bidan;
- Cohen-Solal, Alain
Publication type:
journal article
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on β-blockers in SURVIVE†.
Published in:
European Journal of Heart Failure, 2009, v. 11, n. 3, p. 304, doi. 10.1093/eurjhf/hfn045
By:
- Mebazaa, Alexandre;
- Nieminen, Markku S.;
- Filippatos, Gerasimos S.;
- Cleland, John G.;
- Salon, Jeffrey E.;
- Thakkar, Roopal;
- Padley, Robert J.;
- Bidan Huang;
- Cohen-Solal, Alain
Publication type:
Article
Flushing Assessment Tool (FAST).
Published in:
Clinical Drug Investigation, 2009, v. 29, n. 4, p. 215, doi. 10.2165/00044011-200929040-00001
By:
- Kawata, Ariane K.;
- Revicki, Dennis A.;
- Thakkar, Roopal;
- Ping Jiang;
- Krause, Scott;
- Davidson, Michael H.;
- Punzi, Henry A.;
- Padley, Robert J.
Publication type:
Article
Niacin Extended-Release Therapy in Phase III Clinical Trials is Associated with Relatively Low Rates of Drug Discontinuation due to Flushing and Treatment-Related Adverse Events.
Published in:
American Journal of Cardiovascular Drugs, 2011, v. 11, n. 3, p. 179, doi. 10.2165/11592560-000000000-00000
By:
- Brinton, Eliot A.;
- Kashyap, Moti L.;
- Vo, Anthony N.;
- Thakkar, Roopal B.;
- Ping Jiang;
- Padley, Robert J.
Publication type:
Article
Acetylsalicylic Acid Reduces Niacin Extended-Release-Induced Flushing in Patients with Dyslipidemia.
Published in:
American Journal of Cardiovascular Drugs, 2009, v. 9, n. 2, p. 69, doi. 10.1007/BF03256578
By:
- Thakkar, Roopal B.;
- Kashyap, Moti L.;
- Lewin, Andrew J.;
- Krause, Scott L.;
- Ping Jiang;
- Padley, Robert J.
Publication type:
Article
Pharmacokinetics and pharmacodynamic effects of ABT-627, an oral ETA selective endothelin antagonist, in humans.
Published in:
British Journal of Clinical Pharmacology, 2000, v. 49, n. 6, p. 562, doi. 10.1046/j.1365-2125.2000.00171.x
By:
- Verhaar, Marianne C.;
- Grahn, Amy Y.;
- van Weerdt, Anton W.M.;
- Honing, Marina L.H.;
- Morrison, Paul J.;
- Yang, Yonghong P.;
- Padley, Robert J.;
- Rabelink, Ton J.
Publication type:
Article
ABT‐122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin‐17A, in Patients With Rheumatoid Arthritis With an Inadequate Response to Methotrexate.
Published in:
Arthritis & Rheumatology, 2018, v. 70, n. 11, p. 1710, doi. 10.1002/art.40580
By:
- Genovese, Mark C.;
- Weinblatt, Michael E.;
- Aelion, Jacob A.;
- Mansikka, Heikki T.;
- Peloso, Paul M.;
- Chen, Kun;
- Li, Yihan;
- Othman, Ahmed A.;
- Khatri, Amit;
- Khan, Nasser S.;
- Padley, Robert J.
Publication type:
Article
Safety, Tolerability, and Pharmacodynamics of ABT-122, a Tumor Necrosis Factor- and Interleukin-17-Targeted Dual Variable Domain Immunoglobulin, in Patients With Rheumatoid Arthritis.
Published in:
Arthritis & Rheumatology, 2017, v. 69, n. 12, p. 2283, doi. 10.1002/art.40319
By:
- Fleischmann, Roy M.;
- Wagner, Frank;
- Kivitz, Alan J.;
- Mansikka, Heikki T.;
- Khan, Nasser;
- Othman, Ahmed A.;
- Khatri, Amit;
- Hong, Feng;
- Jiang, Ping;
- Ruzek, Melanie;
- Padley, Robert J.
Publication type:
Article
Pharmacokinetics, Safety and Tolerability of ABT-494, a Novel Selective JAK 1 Inhibitor, in Healthy Volunteers and Subjects with Rheumatoid Arthritis.
Published in:
2016
By:
- Mohamed, Mohamed-Eslam;
- Camp, Heidi;
- Jiang, Ping;
- Padley, Robert;
- Asatryan, Armen;
- Othman, Ahmed;
- Mohamed, Mohamed-Eslam F;
- Camp, Heidi S;
- Padley, Robert J;
- Othman, Ahmed A
Publication type:
journal article

Found: 17